| Financial Year |
March 31 2023 |
| Monetary Funds |
374,601,940.01 |
| Held-for-trading Financial Assets |
10,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
227,995,848.04 |
| Advances to Suppliers |
2,386,293.18 |
| Other Receivables |
17,268,390.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
14,666,692.27 |
| Inventories |
968,040,641.42 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
165,146,025.46 |
| Total Current Assets |
1,765,439,138.77 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
158,826,809.08 |
| Investment Properties |
107,182,462.69 |
| Fixed Assetes |
1,734,913,907.87 |
| Under-construction Projects |
16,738,985.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
94,314,706.07 |
| R&D expenses |
-- |
| Goodwill |
41,933,586.79 |
| Long-Term Deferred and Prepaid Expenses |
3,513,874.19 |
| Deferred Income Tax Assets |
51,229,352.56 |
| Other Non-Current Assets |
20,577,229.05 |
| Sub-Total of Non-Current Assets |
2,414,155,517.25 |
| Total Assets |
4,179,594,656.02 |
| Short-Term Loans |
50,086,777.78 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
192,855,185.08 |
| Accounts Received In Advance |
2,529,496.10 |
| Employee Compensation Payable |
33,051,106.37 |
| Taxes Payable |
17,625,401.68 |
| Interest Payable |
-- |
| Dividend Payable |
46,920.00 |
| Other payables |
31,224,629.10 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
25,605,188.05 |
| Other Current Liabilities |
79,638,807.95 |
| Sub-Total of Current Liabilities |
1,330,628,352.93 |
| Long-term Loans |
285,917,940.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
4,402,400.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
2,281,361.93 |
| Deferred Income Tax Liabilities |
1,167,918.06 |
| Other Non-Current Liabilities |
1,244,177.16 |
| Sub-Total of Non-Current Liabilities |
560,212,467.43 |
| Total Liabilities |
1,890,840,820.36 |
| Paid-In Capital(Or Share Stock) |
457,951,455.00 |
| Capital Surplus |
1,649,540,574.38 |
| Surplus Reserve |
24,874,859.91 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
104,719,973.28 |
| Minority Stockholder's Interest |
51,666,973.09 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,237,086,862.57 |
| Owner's Equity（Stockholder's Equity） |
2,288,753,835.66 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,179,594,656.02 |
